Literature DB >> 11717655

Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility.

J A Simoes1, A Aroutcheva, I Heimler, S Shott, S Faro.   

Abstract

OBJECTIVE: Our purpose was to investigate the bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and resistance to metronidazole. STUDY
DESIGN: Bacteriocin susceptibility of 36 G vaginalis clinical isolates was tested against a vaginal strain of Lactobacillus acidophilus by a growth-inhibition method. The relationship to biotype, genotype, and resistance to metronidazole were analyzed by the chi2 test and Fisher exact test.
RESULTS: Eight G vaginalis strains (22%) were bacteriocin-resistant. Biotypes 5 and 7 were found to be the most frequent among these resistant strains. Eight (42%) of the 19 isolates classified as biotype 5, 6, or 7 were bacteriocin-resistant compared with none of the isolates that were classified as other biotypes (P <.01). Biotype 5 was found in higher prevalence among the isolates resistant to bacteriocin (62%) than among the susceptible isolates (14%) (P =.01). Genotype B was found more frequently among the bacteriocin-resistant strains, but this finding was not statistically significant (P =.71). Seven (88%) bacteriocin-resistant strains were also resistant to metronidazole.
CONCLUSION: An association between biotype and an increased resistance to bacteriocin was found. The ability of G vaginalis to resist the antibacterial activity of Lactobacillus bacteriocin may be a pivotal factor in understanding bacterial vaginosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717655     DOI: 10.1067/mob.2001.118144

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Lactocin 160, a Bacteriocin Produced by Vaginal Lactobacillus rhamnosus, Targets Cytoplasmic Membranes of the Vaginal Pathogen, Gardnerella vaginalis.

Authors:  Yevgeniy Turovskiy; Richard D Ludescher; Alla A Aroutcheva; Sebastian Faro; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2009-01-20       Impact factor: 4.609

Review 2.  The role of metagenomics in understanding the human microbiome in health and disease.

Authors:  Rebeca Martín; Sylvie Miquel; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  Virulence       Date:  2014-02-11       Impact factor: 5.882

3.  Vulvovestibular Syndrome and Vaginal Microbiome: A Simple Evaluation.

Authors:  Maria Vadala; Christian Testa; Laura Coda; Stefania Angioletti; Rosanna Giuberti; Carmen Laurino; Beniamino Palmieri
Journal:  J Clin Med Res       Date:  2018-07-31

4.  Vaginal microbiota and the use of probiotics.

Authors:  Sarah Cribby; Michelle Taylor; Gregor Reid
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-03-29

5.  Draft Genome Sequence of a Metronidazole-Resistant Gardnerella vaginalis Isolate.

Authors:  Jessica A Schuyler; Sean G Chadwick; Eli Mordechai; Martin E Adelson; Scott E Gygax; David W Hilbert
Journal:  Genome Announc       Date:  2015-09-03

6.  Draft Genome Sequence of a Metronidazole-Resistant Derivative of Gardnerella vaginalis Strain ATCC 14019.

Authors:  Jessica A Schuyler; Eli Mordechai; Martin E Adelson; Scott E Gygax; David W Hilbert
Journal:  Genome Announc       Date:  2015-11-12

Review 7.  The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa.

Authors:  Amy Liese Cole; Alexander M Cole
Journal:  Antibiotics (Basel)       Date:  2014-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.